IOVA IOVANCE BIOTHERAPEUTICS INC
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 15 analyst firms say about IOVANCE BIOTHERAPEUTICS INC: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
16 rated views · 17 analyst/firm records · 15 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8061
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8055
Recent analyst activity · last 90 days
Our tracked history has 16 reports on IOVA from 11 analyst firms in the last 90 days (15 firms in the past year).
Comparing each firm's latest target with its previous one: 2 raised their price target, 3 left it unchanged and 5 have their first observed target in the past year.
Ratings, latest available report against the previous one: 1 upgrade and 0 downgrades.
Latest observed target change: UBS raised its target from $7.00 (set 20 Aug 2026) to $8.00 on 3 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Baird | Colleen Kusy | Hold | 8 Oct 2026 | 11.00 USD |
| Baird | Jack K Allen | Hold | 17 Aug 2026 | 11.00 USD |
| Barclays | Etzer Darout | Buy | 13 Oct 2026 | 18.00 USD |
| Chardan Capital Markets | Geulah Livshits | Buy | 7 May 2026 | 14.00 USD |
| Citigroup | Unnamed analyst | Buy | 7 Aug 2026 | — |
| Citizens JMP | Reni Benjamin | Buy | 7 Aug 2026 | 8.00 USD |
| Goldman Sachs | Andrea Newkirk | Buy | 24 Sep 2026 | 15.00 USD |
| H.C. Wainwright | Joseph Pantginis | Buy | 29 Sep 2026 | 20.00 USD |
| Jefferies | Andrew Tsai | Buy | 13 Oct 2026 | 20.00 USD |
| Mizuho | Mara Goldstein | Buy | 18 Aug 2026 | 11.00 USD |
| Mizuho | Salim Syed | Buy | 18 Aug 2026 | 11.00 USD |
| TD Cowen | Nicholas Lorusso | Buy | 24 Aug 2026 | Conflicting reports · excluded |
| Truist | Unnamed analyst | Hold | 25 Mar 2026 | — |
| UBS | David Dai | Hold | 20 Aug 2026 | 7.00 USD |
| Weiss Ratings | Unnamed analyst | — | 29 Sep 2026 | — |
| Wells Fargo | Yanan Zhu | Buy | 30 Sep 2026 | 18.00 USD |
| Data feed RESEARCH | Research Team | Buy | 26 Oct 2026 | 16.00 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 04:09 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.